Alternative splicing during neural development is shaped by a multilayered genetic program that controls exon choice to generate neuronal diversity. Core elements include cis-regulatory sequences within pre-mRNAs, trans-acting RNA-binding proteins, and higher-order influences from transcription and chromatin; together these mechanisms set timing, cell-type specificity, and plasticity of splicing decisions.
RNA-binding proteins and cis-regulatory elements
Short motifs in exons and flanking introns act as splicing enhancers and silencers that recruit or repel splicing factors. Decades of work mapping in vivo targets has established families of neuronal regulators. Robert Darnell at Rockefeller University and Jernej Ule at University College London characterized the Nova family, showing how position-dependent binding controls inclusion or skipping of neuronal exons. Douglas L. Black at University of California Los Angeles documented the developmental switch between PTBP1 and PTBP2, where downregulation of PTBP1 during differentiation releases repression of neuronal exons. Manuel Irimia at Centre for Genomic Regulation and Ben Blencowe at University of Toronto described the critical role of the splicing factor SRRM4 nSR100 in promoting inclusion of tiny neuronal microexons—a program conserved across vertebrates and altered in some neurodevelopmental conditions. These trans-factors interact combinatorially with cis-elements, so the same pre-mRNA can be processed differently as regulatory factor levels change during development.
Transcriptional dynamics, chromatin, and noncoding influences
Splicing is co-transcriptional, making RNA polymerase II elongation speed and the chromatin landscape influential variables. Alberto Kornblihtt at the University of Buenos Aires has reviewed how slower elongation can favor inclusion of alternative exons by extending the window for splice-site recognition, while histone marks and nucleosome positioning modulate access to cis-elements. Noncoding RNAs and RNA secondary structure further modulate factor binding in subtle and context-dependent ways.
These regulatory layers create splicing trajectories that define neuronal identity, synaptic proteins, and signaling pathways. Misregulation can have substantive consequences: research by Manuel Irimia at Centre for Genomic Regulation and Ben Blencowe at University of Toronto linked misregulated microexons to autism spectrum disorder, illustrating how precise exon-level control is relevant to human neurodevelopment and disease. Environment, evolutionary lineage, and regional brain programs shape splicing outcomes, contributing to species-specific neural complexity and to territorial patterns of gene expression across brain regions.
Understanding these mechanisms improves interpretation of genetic variants that alter splicing, guides therapeutic approaches that target splicing regulators or RNA elements, and frames how developmental timing and tissue context produce the molecular diversity essential for nervous system function. Nuanced modulation rather than binary switches typically underlies biologically meaningful splicing changes during neural maturation.